StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Axis Securities

BUYMax Healthcare Institute Limited
Max Healthcare Institute share price target & all analyst calls

byAxis SecuritiesHorizon: NA (inferred 1 year)4 Nov 2026via Institutional / Brokerage Research

Entry₹927.15Inferred
Target₹1,110
Total upside +19.72%
Stop lossNot given
CMP₹9341d ago
Active+0.74%+18.84%upside left 12 mo left
Follow Axis Securities for new calls(69% target hit, 843 closed calls)Get alertsWatch MAXHEALTH for new buy/sell callsGet alertsSee 25 other Long-term calls on MAXHEALTHSee 541 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:25 pm IST
12 supporting12 neutral7 opposing
Supports the BUY call (12)

15 other SEBI-registered advisors have active long-term BUY calls on this stock, with 6 issued in the last 14 days

Advisor consensus · same horizon·4 Nov · 3d ago

Max Healthcare reported Q2 revenue of Rs. 3,219 crore, a 20% year-on-year increase, and a profit after tax of Rs. 448 crore, representing 10% year-on-year growth.

BSE · Company Update·30 Oct · 1w ago

(opens in new tab)

Max Healthcare reported Q2 revenue of Rs 3219 crore, up 20% YoY, and a PAT of Rs 448 crore, up 10% YoY.

NSE · Press Release·30 Oct · 1w ago

(opens in new tab)

Max Healthcare reported Q2 FY27 financial results, approved capital expenditure of ~190 Crore for hospital expansions in Noida and Vaishali, and updated the project cost for its Gurugram hospital to ~

BSE · Board Meeting·30 Oct · 1w ago

(opens in new tab)

Max Healthcare reported consolidated financial results for the quarter and half-year ended September 30, 2026, alongside approval for capital expenditure of approximately 190 crore for hospital expans

NSE · Outcome of Board Meeting·30 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (12)

Nothing found in this tip’s window yet.

Weighs against the BUY call (7)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·6 Nov · yesterday

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·13 Oct · 4w ago

Macquarie sees mid-teens earnings risk for Max Health stock

NewsGoogle News·12 Oct · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Max Healthcare Institute

All analyst calls on Max Healthcare Institute

More from Axis Securities

Every call and its outcome